HRT Financial’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$155K Buy
+39,041
New +$107K ﹤0.01% 3480
2026
Q1
– Sell
-61,210
Closed -$149K – 4732
2025
Q4
$149K Buy
+61,210
New +$266K ﹤0.01% 2705
2025
Q2
– Sell
-24,131
Closed -$202K – 3516
2025
Q1
$202K Sell
24,131
-86,070
-78% -$774K ﹤0.01% 2028
2024
Q4
$819K Sell
110,201
-60,189
-35% -$403K ﹤0.01% 1179
2024
Q3
$988K Buy
+170,390
New +$1.09M ﹤0.01% 1242

Other funds holding TMCI

HRT Financial's TMCI Position: Q2 2026 in Review

HRT Financial opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 39,041 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #3480 among its holdings. This is a return to the name: HRT Financial previously reported a position in TMCI as recently as Q4 2025.

HRT Financial first reported a position in TMCI in Q3 2024 and has held it in 5 quarters since. The position peaked at $988K in Q3 2024. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • HRT Financial held 39,041 shares of Treace Medical Concepts worth $155K as of Q2 2026.
  • Treace Medical Concepts was a new HRT Financial position in Q2 2026.
  • Treace Medical Concepts made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3480 holding.
  • HRT Financial first reported a position in Treace Medical Concepts in Q3 2024 and has held it in 5 quarters since.
  • HRT Financial's Treace Medical Concepts position peaked at $988K in Q3 2024.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.